Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

International Journal of Cardiology

Volumn 134, Issue 2, 2009, Pages 189-194

  Cecchi, Emanuele ^a,b   Liotta, Agatina Alessandriello ^a   Gori, Anna Maria ^a   Valente, Serafina ^a   Giglioli, Cristina ^a   Lazzeri, Chiara ^a   Sofi, Francesco ^a   Gensini, Gian Franco ^a,b   Abbate, Rosanna ^a   Mannini, Lucia ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Acute myocardial infarction; Blood viscosity; Infarct size

Indexed keywords

CREATINE KINASE; TROPONIN I;

ADULT; AGED; ARTICLE; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; ERYTHROCYTE DEFORMABILITY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY DYSFUNCTION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLASMA VISCOSITY; PRIORITY JOURNAL; REPERFUSION; ST SEGMENT ELEVATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BLOOD VISCOSITY; CORONARY CIRCULATION; CREATINE KINASE; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; HEMORHEOLOGY; HUMANS; LINEAR MODELS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; STROKE VOLUME; TROPONIN I; YOUNG ADULT;

EID: 64849110062     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.01.039     Document Type: Article

References (39)

1. Sargento L., do Rosario H.S., Perdigão C., Monteiro J., Saldanha C., and Martins e Silva J. Biohemorheologic factors and cardiovascular events curve in survivors of transmural acute myocardial infarct-24-month follow-up. Rev Port Cardiol 21 (2002) 165-171
2. Sargento L., Saldanha C., Monteiro J., Perdigão C., and Martins e Silva J. Evidence of prolonged disturbances in the haemostatic, hemorheologic and inflammatory profiles in transmural myocardial infarction survivors. Thromb Haemost 89 (2003) 892-903
3. Marton Z., Horvath B., Alexy T., et al. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes. Clin Hemorheol Microcirc 29 (2003) 81-94
4. Caimi G., Hoffmann E., Montana M., et al. Haemorheological pattern in young adults with acute myocardial infarction. Clin Hemorheol Microcirc 29 (2003) 11-18
5. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110 (2004) 588-636
6. Turer A.T., Mahaffey K.W., Gallup D., et al. Enzyme estimates of infarct size correlate with functional and clinical outcome in the setting of ST-segment elevation myocardial infarction. Curr Control Trials Cardiovasc Med 6 (2005) 12
7. Haase J., Bayar R., Hackenbroch M., et al. Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol 17 (2004) 367-373
8. Panteghini M., Cuccia C., Bonetti G., Giubbini R., Pagani F., and Bonini E. Single-point cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. Clin Chem 48 (2002) 1432-1436
9. Licka M., Zimmermann R., Zehelein J., Dengler T.J., Katus H.A., and Kübler W. Troponin T concentrations at 72 hours after myocardial infarction as a serological estimate of infarct size. Heart 87 (2002) 520-524
10. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1 (2003) S5-S20
13. Mannini L., Paniccia R., Cecchi E., et al. Reduced erythrocyte deformability and hypercoagulability in idiopathic sudden sensorineural hearing loss. Clin Hemorheol Microcirc 33 (2005) 47-55
14. Wasilewski J., Turczynski B., Kowalik V., Osadnik T., and Polonski L. Evaluation of hemorheological profiles in patients with no-reperfusion phenomenon in acute ST elevation myocardial infarction treated by primary percutaneous coronary intervention. J Vasc Res 42 Suppl 2 (2005) 49
15. Wasilewski J., Turczynski B., Slowinska L., Kowalik V., Osadnik T., and Polonski L. Haemorheological factors and myocardial reperfusion in patients with ST-elevation myocardial infarction undergoing primary coronary intervention. Kardiol Pol 65 (2007) 778-785
16. McKechnie R.S., Smith D., Montoye C., et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 110 (2004) 271-277
17. Nikolsky E., Mehran R., Aymong E.D., et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 94 (2004) 1023-1027
18. Inoue F., Hashimoto T., Tabuse H., and Saito Y. Hematocrit as an indicator for coronary intervention in patients with acute myocardial infarction. J Cardiol 42 (2003) 241-247
19. Rao S.V., Jollis J.G., Harrington R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
20. Shinozaki K., Tamura A., Watanabe T., et al. Significance of neutrophil counts after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Circ J 69 (2005) 526-529
21. Kosuge M., Kimura K., Ishikawa T., et al. Relation between white blood cell counts and myocardial reperfusion in patients with recanalized anterior acute myocardial infarction. Circ J 68 (2004) 526-531
22. Sezer M., Okcular I., Goren T., et al. Association of haematological indices with the degree of microvascular injury in patients with acute anterior wall myocardial infarction treated with primary percutaneous coronary intervention. Heart 93 (2007) 313-318
23. De Sutter J., De Buyzere M., Gheeraert P., et al. Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction. Atherosclerosis 157 (2001) 189-196
24. Wasilewski J., Osadnik T., and Polonski L. High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention. Kardiol Pol 64 (2006) 967-972
25. Shapira I., Rotstein R., Fusman R., et al. Combined leukocyte and erythrocyte aggregation in patients with acute myocardial infarction. Int J Cardiol 78 (2001) 299-305
26. Sherman D.G., Atkinson R.P., Chippendale T., et al. Intravenous ancrod for treatment of acute ischemic stroke. The STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA 283 (2000) 2395-2403
27. Ben-Ami R., Sheinman G., Yedgar S., et al. Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability. Thromb Res 105 (2002) 487-492
28. Sezer M., Oflaz H., Goren T., et al. Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med 356 (2007) 1823-1834
29. Arntz H.R., Perchalla G., Roll D., Heitz J., Schafer J.H., and Schroder R. Blood rheology in acute myocardial infarction: effects of high-dose i.v. streptokinase compared to placebo. Eur Heart J 13 (1992) 275-280
30. Ga{ogonek}sior M., Gierlotka T., Lekston A., et al. Relation between time of pain and long-term outcome in patients with acute myocardial infarction transferred to primary angioplasty or angioplasty facilitated with thrombolysis. J Am Coll Cardiol 43 Suppl A (2004) 264A
31. Bartorelli A.L. Hyperoxemic perfusion for treatment of reperfusion microvascular ischemia in patients with myocardial infarction. Am J Cardiovasc Drugs 3 (2003) 253-263
32. Licker M., Mariethoz E., Costa M.J., and Morel D. Cardioprotective effects of acute isovolemic hemodilution in a rat model of transient coronary occlusion. Crit Care Med 33 (2005) 2302-2308
33. Tucker W.Y., Bean J., Vandevanter S., and Cohn L.H. The effect of hemodilution on experimental myocardial infarct size. Eur Surg Res 12 (1980) 1-11
34. Sjoquist P.O., Kareld L., Wahlund G.C., and Holmberg S. Moderate normovolaemic haemodilution increases regional myocardial blood flow but has no effect on experimental infarct size. Scand J Clin Lab Invest 46 (1986) 677-683
35. Licker M., Ellenberger C., Sierra J., Kalangos A., Diaper J., and Morel D. Cardioprotective effects of acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery. Chest 128 (2005) 838-847
36. Walzl M., Lechner H., Walzl B., and Schied G. Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen. Stroke 24 (1993) 1447-1451
37. Zhang L., Pu K., Zhang S.Y., and Ren W.Q. Blood rheological properties are strongly related to the metabolic syndrome in middle-aged Chinese. Int J Cardiol 112 (2006) 229-233
38. Clavijo L.C., Pinto T.L., Kuchulakanti P.K., et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 7 (2006) 7-11
39. Lowe G.D. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 3 (2005) 1618-1627